Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diphthamide biosynthesis protein 3 (DPH3) is a small, CSL-type zinc finger-containing protein essential for the post-translational modification of elongation factor 2 (eEF2) at a specific histidine residue, resulting in the diphthamide group—this modification is the target for ADP-ribosylation by bacterial toxins such as diphtheria toxin and Pseudomonas exotoxin A, which inactivates eEF2 and halts protein synthesis. DPH3 acts as an electron donor, transferring electrons to and helping maintain the [4Fe–4S] clusters in the DPH1–DPH2 enzyme complex, enabling the critical first step of diphthamide biosynthesis. DPH3 also participates in tRNA modifications via interaction with the elongator complex, and may play broader roles in cellular processes including transcription regulation and endocytosis, though these are less well characterized. DPH3 is not itself considered a direct therapeutic target, but its function is crucial for the sensitivity of cells to certain bacterial toxins.
Not applicable (DPH3 itself is not targeted by therapeutics; rather, its function is essential for post-translational modification of elongation factor 2, which is the target for diphtheria toxin and Pseudomonas exotoxin A)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diphthamide biosynthesis protein 3 (DPH3).